Mercer Global Advisors Inc. ADV Increases Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Mercer Global Advisors Inc. ADV lifted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 119.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,097 shares of the company’s stock after acquiring an additional 3,862 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in Acadia Healthcare were worth $479,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of ACHC. Vanguard Group Inc. lifted its holdings in Acadia Healthcare by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company’s stock valued at $689,065,000 after acquiring an additional 30,296 shares during the period. William Blair Investment Management LLC grew its holdings in Acadia Healthcare by 20.7% in the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after buying an additional 604,070 shares during the period. Bank of New York Mellon Corp grew its holdings in Acadia Healthcare by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,249,369 shares of the company’s stock valued at $84,382,000 after buying an additional 77,509 shares during the period. Avidity Partners Management LP grew its holdings in Acadia Healthcare by 61.8% in the 4th quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock valued at $89,944,000 after buying an additional 441,692 shares during the period. Finally, Iron Triangle Partners LP grew its holdings in Acadia Healthcare by 14.0% in the 1st quarter. Iron Triangle Partners LP now owns 902,813 shares of the company’s stock valued at $71,521,000 after buying an additional 110,820 shares during the period.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $63.28 on Friday. The company has a market capitalization of $5.87 billion, a price-to-earnings ratio of -452.00, a price-to-earnings-growth ratio of 2.19 and a beta of 1.30. The business has a 50 day simple moving average of $74.23 and a 200-day simple moving average of $71.66. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a twelve month low of $53.22 and a twelve month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The company had revenue of $796.00 million during the quarter, compared to analyst estimates of $784.38 million. During the same quarter in the previous year, the firm posted $0.92 EPS. The firm’s quarterly revenue was up 8.8% on a year-over-year basis. As a group, equities research analysts expect that Acadia Healthcare Company, Inc. will post 3.51 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on ACHC shares. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research note on Monday, August 19th. Deutsche Bank Aktiengesellschaft lifted their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Royal Bank of Canada reissued an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a research report on Friday, September 20th. Finally, Barclays reduced their price target on Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating on the stock in a research report on Thursday, August 1st. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $87.44.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.